RO7656594

· Genentech, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for RO7656594, covering 2026-04-20 to 2026-04-20. Get the full timeline:

Most recent: Clinical Trial Update: A Study Evaluating the Safety, Pharmacokinetics, and Activity of RO7656594 In Participants With Advanced or Metastatic Prostate Cancer [Phase 1]

See pricing